These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9348570

  • 1. A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish Group for the Treatment of Gastrointestinal Tumors (TTd Group).
    Abad A, Navarro M, Sastre J, Marcuello E, Aranda E, Gallén M, Fernandez-Martos C, Martín C, Diaz-Rubio E.
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):53-7. PubMed ID: 9348570
    [Abstract] [Full Text] [Related]

  • 2. A phase II trial. Oral UFT and leucovorin in patients with advanced gastric carcinoma.
    Kim YH, Shin SW, Kim BS, Park YT, Kim JG, Kim JS.
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):119-23. PubMed ID: 9348583
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.
    Pazdur R, Lassere Y, Rhodes V, Ajani JA, Sugarman SM, Patt YZ, Jones DV, Markowitz AB, Abbruzzese JL, Bready B.
    J Clin Oncol; 1994 Nov; 12(11):2296-300. PubMed ID: 7964943
    [Abstract] [Full Text] [Related]

  • 4. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
    Aranda E, Cervantes A, Carrato A, Antón-Torres A, Massutí T, Fernández-Martos C, Díaz-Rubio E.
    J Infus Chemother; 1996 Nov; 6(3):118-22. PubMed ID: 9229321
    [Abstract] [Full Text] [Related]

  • 5. UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
    Díáz-Rubio E, Sastre J, Abad A, Navarro M, Aranda E, Carrato A, Gallén M, Marcuello E, Rifá J, Massuti T, Cervantes A, Antón A, Fernández Martos C.
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):35-40. PubMed ID: 10442357
    [Abstract] [Full Text] [Related]

  • 6. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J, González Barón M, García-Girón C, Espinosa E, García-Alfonso P, Belón J, Blanco E, Garrido P, Ordónez A, Gómez-Navarro J, Zamora P.
    Cancer; 1996 Jul 15; 78(2):211-6. PubMed ID: 8673994
    [Abstract] [Full Text] [Related]

  • 7. Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients.
    Rosati G, Cordio S, Tucci A, Blanco G, Bordonaro R, Reggiardo G, Manzione L.
    Oncology; 2005 Jul 15; 69(2):122-9. PubMed ID: 16118508
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT, Yoon SY, Shin SW, Kim BS, Mok YJ, Kim CS, Hyun JH, Kim JS, Kim YH.
    Cancer; 2001 Jun 15; 91(12):2288-93. PubMed ID: 11413517
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K, Hoff PM, Ohtsu A, Loehrer PJ, Hyodo I, Wadler S, Wadleigh RG, O'Dwyer PJ, Muro K, Yamada Y, Boku N, Nagashima F, Abbruzzese JL.
    J Clin Oncol; 2004 Sep 01; 22(17):3466-74. PubMed ID: 15277535
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
    Hochster HS, Luo W, Popa EC, Lyman BT, Mulcahy M, Beatty PA, Benson AB.
    J Clin Oncol; 2007 Dec 01; 25(34):5397-402. PubMed ID: 18048821
    [Abstract] [Full Text] [Related]

  • 11. Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials.
    Bin Q, Li J, Liao C, Cao Y, Gao F.
    Colorectal Dis; 2011 Aug 01; 13(8):837-45. PubMed ID: 20050863
    [Abstract] [Full Text] [Related]

  • 12. Oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
    Meropol NJ, Noel D, Sonnichsen DS, Birkhofer MJ.
    Oncology (Williston Park); 1997 Sep 01; 11(9 Suppl 10):22-5. PubMed ID: 9348562
    [Abstract] [Full Text] [Related]

  • 13. UFT plus leucovorin for metastatic colorectal cancer: Japanese experience.
    Ichikawa W, Nihei Z, Uetake H, Yamada H, Shirota Y, Sugihara K.
    Oncology (Williston Park); 2000 Oct 01; 14(10 Suppl 9):41-3. PubMed ID: 11098491
    [Abstract] [Full Text] [Related]

  • 14. Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.
    Feliu J, González Barón M, Espinosa E, García Girón C, de la Gándara I, Espinosa J, Colmenarejo A, Jalón JI, Fernández Y, de Castro J.
    Cancer; 1997 May 15; 79(10):1884-9. PubMed ID: 9149013
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule.
    Pazdur R, Lassere Y, Diaz-Canton E, Bready B, Ho DH.
    Invest New Drugs; 1997 May 15; 15(2):123-8. PubMed ID: 9220291
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study.
    González-Barón M, Feliu J, de la Gándara I, Espinosa E, Colmenarejo A, Martínez-Martínez B, Blanco E, García-Girón C, Juárez F, Garrido P.
    Eur J Cancer; 1995 Dec 15; 31A(13-14):2215-9. PubMed ID: 8652245
    [Abstract] [Full Text] [Related]

  • 18. Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma.
    Kim YH, Kim BS, Seo JH, Choi CW, Kim JS, Chun HJ, Hyun JH, Kim JS.
    Oncology (Williston Park); 1999 Jul 15; 13(7 Suppl 3):64-8. PubMed ID: 10442365
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
    Mizushima T, Mizuno H, Ito T, Hoki M, Souma Y, Iwamoto T, Ozawa H, Kanou T, Nakamori Y, Iwase K.
    Gan To Kagaku Ryoho; 2006 Jul 15; 33(7):941-4. PubMed ID: 16835484
    [Abstract] [Full Text] [Related]

  • 20. Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study).
    Nishina T, Moriwaki T, Shimada M, Higashijima J, Sakai Y, Masuishi T, Ozeki M, Amagai K, Negoro Y, Indo S, Denda T, Sato M, Yamamoto Y, Nakajima G, Mizuta M, Takahashi I, Hiroshima Y, Ishida H, Maeba T, Hyodo I.
    Clin Colorectal Cancer; 2016 Sep 15; 15(3):236-42. PubMed ID: 26778644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.